A lapachol derivative active against mouse lymphocytic leukemia P-388

Area of Science:

• Organic Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Lapachol and its synthesized analogs exhibit activity against rat tumor Walker 256 carcinosarcoma.
• A hundred synthesized analogs were evaluated for anti-cancer properties.

Purpose of the Study:

• To synthesize and evaluate novel lapachol derivatives for anti-cancer activity.
• To investigate the efficacy of acetylglucosylated lapachol against mouse lymphocytic leukemia P-388.

Main Methods:

• Synthesis of lapachol analogs, including acetylglucosylation.
• In vivo testing of the acetylglucosylated compound in mice inoculated with leukemic cells.
• Characterization of the synthesized compound using spectral data (UV, IR, 1H NMR, MS).

Main Results:

• Lapachol and its analogs demonstrated activity against Walker 256 carcinosarcoma.
• Acetylglucosylation of lapachol yielded a compound with enhanced activity against mouse lymphocytic leukemia P-388.
• Treatment with the acetylglucosylated compound increased the lifespan of tumor-bearing mice by 80% compared to controls.

Conclusions:

• Lapachol derivatives represent a promising class of anti-cancer agents.
• Acetylglucosylation is a viable strategy for enhancing the therapeutic potential of lapachol.
• The synthesized acetylglucosylated lapachol derivative warrants further investigation as a potential anti-leukemic drug.